Live Breaking News & Updates on China national biotech group

Stay informed with the latest breaking news from China national biotech group on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in China national biotech group and stay connected to the pulse of your community

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China – Padovanews

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

Vienna , Wien , Austria , Beijing , China , New-zealand , Lanzhou , Gansu , Leobendorf , Niederörreich , Hong-kong , Australia

Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in …

Australia , Austria , Hong-kong , China , Vienna , Wien , Leobendorf , Niederörreich , New-zealand , Beijing , Brazil , Lanzhou

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

/PRNewswire/ -- Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its...

Brazil , Beijing , China , Austria , Lanzhou , Gansu , Australia , Canada , Hong-kong , New-zealand , Leobendorf , Niederörreich

Polio now only in Pakistan, Afghanistan

China's experience in eradicating polio and fast, effective stamping out of isolated clusters in recent years may be of value to the rest of the world as the global mission to end the infectious disease stands at a critical juncture, health experts said recently.

Beijing , China , Afghanistan , Nigeria , Pakistan , Chinese , Shen-hongbing , Aidan-oleary , Margaret-chan-fung-fu-chun , Xinjiang-uygur , Zhang-yuntao , Yu-zirong

Chinese experts stress improving seniors' immunization as society rapidly ages-Xinhua

Chinese experts stress improving seniors' immunization as society rapidly ages-

China , Beijing , Feng-zijian , Shanxi , Chinese , Zhang-yuntao , Chinese-preventive-medicine-association , National-bureau-of-statistics , Xinhua-health , Chinese-center , China-national-biotech-group , China-daily

Innovative vaccine campaigns called for to better inform elderly

With China's swelling elderly population, health experts have called for developing vaccines to tackle diseases primarily affecting seniors and devising innovative methods to expand vaccine acceptance among the age group.

Feng-zijian , Shanxi , China , Wuxi , Jiangsu , Shanghai , Chinese , Wang-huaqing , Li-xiuling , Liu-hongyan , Liu-junhua , Zhang-yuntao

Vaccinating elderly key to exiting pandemic

An abundance of data has shown that domestic COVID-19 vaccines are safe and effective for the elderly and other vulnerable groups, drugmakers have said, as experts reiterated the importance of expanding immunization coverage in order to cope with the epidemic.

Argentina , China , Xia-gang , Guangdong , Shanghai , United-arab-emirates , Hungary , Sri-lanka , Chinese , Zhang-wenhong , Virology-conference-of-the-chinese-medical-association , Shanghai-huashan-hospital-affiliated-to-fudan-university

Sinopharm wins approval for inhaled Omicron antibody trials

Chinese drugmaker Sinopharm said on Monday it has obtained approval to conduct clinical trials of an inhaled monoclonal antibody against the novel coronavirus, a potentially significant weapon against the dominant Omicron variant.

Hangzhou , Zhejiang , China , Chinese , National-medical-products-administration-on , China-national-biotech-group , Battle-against-novel , National-biotech-group , National-medical-products-administration ,

Three China-developed monkey pox vaccines prove effective

China National Biotech Group (CNBG) on Tuesday announced that three mRNA vaccines to fight monkey pox have been proven effective.

China , Yang-xiaoming , China-national-biotech-group , National-biotech-group ,

Sinopharm developing three potential monkeypox vaccines

Chinese drugmaker Sinopharm said on Wednesday that it is developing three potential mRNA vaccines to fight monkeypox.

China , United-states , Chinese , Yang-xiaoming , World-health-organization , China-national-biotech-group ,